0001140361-24-001004.txt : 20240105
0001140361-24-001004.hdr.sgml : 20240105
20240105160531
ACCESSION NUMBER: 0001140361-24-001004
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240105
DATE AS OF CHANGE: 20240105
EFFECTIVENESS DATE: 20240105
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-501744
FILM NUMBER: 24516234
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
D
1
primary_doc.xml
X0708
D
LIVE
0001601485
Elicio Therapeutics, Inc.
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
(857) 209-0050
DELAWARE
None
Angion Biomedica Corp.
Corporation
true
Robert
Connelly
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Executive Officer
Peter
DeMuth
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Executive Officer
Christopher
Haqq
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Executive Officer
Brian
Piekos
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Executive Officer
Julian
Adams
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Carol
Ashe
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Yekaterina
Chudnovsky
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Allen
Nissenson
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Robert
Ruffolo
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Jay
Venkatesan
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Karen
Wilson
451 D Street
5th Floor
Boston
MA
MASSACHUSETTS
02210
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-12-22
false
true
false
0
7047530
7047530
0
false
1
0
0
0
Elicio Therapeutics, Inc.
/s/ Bob Connelly
Bob Connelly
CEO
2024-01-05